Molecular Pathology Unit, Center for Cancer Research, Massachusetts General Hospital, Charlestown, MA 02129, USA, Center for Computational and Integrative Biology, Massachusetts General Hospital, Charlestown, MA 02129, USA, Department of Pathology, Harvard Medical School, Boston, MA 02115, USA, Program in Biological and Biomedical Sciences, Harvard Medical School, Boston, MA 02115, USA, Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 01238, USA, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA and Howard Hughes Medical Institute, Chevy Chase, MD 02815, USA.
Nucleic Acids Res. 2013 Oct;41(19):e181. doi: 10.1093/nar/gkt716. Epub 2013 Aug 14.
Gene-editing nucleases enable targeted modification of DNA sequences in living cells, thereby facilitating efficient knockout and precise editing of endogenous loci. Engineered nucleases also have the potential to introduce mutations at off-target sites of action. Such unintended alterations can confound interpretation of experiments and can have implications for development of therapeutic applications. Recently, two improved methods for identifying the off-target effects of zinc finger nucleases (ZFNs) were described-one using an in vitro cleavage site selection method and the other exploiting the insertion of integration-defective lentiviruses into nuclease-induced double-stranded DNA breaks. However, application of these two methods to a ZFN pair targeted to the human CCR5 gene led to identification of largely non-overlapping off-target sites, raising the possibility that additional off-target sites might exist. Here, we show that in silico abstraction of ZFN cleavage profiles obtained from in vitro cleavage site selections can greatly enhance the ability to identify potential off-target sites in human cells. Our improved method should enable more comprehensive profiling of ZFN specificities.
基因编辑核酸酶使人们能够在活细胞中靶向修饰 DNA 序列,从而有效地实现内源性基因座的敲除和精确编辑。经过工程改造的核酸酶也有可能在非作用靶点上引入突变。这种非预期的改变可能会使实验结果的解释变得复杂,并对治疗应用的开发产生影响。最近,描述了两种改进的方法来鉴定锌指核酸酶(ZFN)的脱靶效应-一种是使用体外切割位点选择方法,另一种是利用整合缺陷型慢病毒插入核酸酶诱导的双链 DNA 断裂。然而,将这两种方法应用于靶向人 CCR5 基因的 ZFN 对,导致鉴定出的脱靶位点在很大程度上不重叠,这增加了可能存在其他脱靶位点的可能性。在这里,我们表明,从体外切割位点选择中获得的 ZFN 切割谱的计算机抽象可以大大提高在人类细胞中鉴定潜在脱靶位点的能力。我们改进的方法应该能够更全面地分析 ZFN 的特异性。